U.S. Stock Market Midday Update: AARD up 12.22%! IPO misleading allegations lead to class action lawsuit, legal risks intensify market volatilityPrice Alert·2 days ago, 11:48 AMAARD+15.79%
China's Personalized mRNA Cancer Therapy Sector Accelerates: How Far Is It From a "DeepSeek Moment"?Unusual Whales·2 days ago, 04:38 AM
Hong Kong stock movement: China National Pharmaceutical Group rises 13.47%, $1.9 billion overseas licensing ignites the marketHK Stock Alerts·Aug 20 at 01:17 AM01177+3.80%
Hong Kong stock movement: China National Pharmaceutical Group rises 18.89%: Half-year net profit doubles, renamed SBP GroupHK Stock Alerts·Aug 19 at 08:53 PM01177+3.80%
U.S. stock night market volatility: FDA restarts review + rating upgrade, Capricor surges 58%Price Alert·Aug 16 at 08:46 PMCAPR-7.97%
The Shangai Composite Index Closes 0.96% LowerTrading Economics·Apr 3 at 02:16 AM600703+0.29%600518-2.16%
KMYY released its performance for the first three quarters, with a net profit attributable to the parent company of 13.08 million yuan, a year-on-year increase of 160.84%Zhitong·Oct 30, 2025 at 03:55 AM600518-2.16%
KMYY released its semi-annual performance, with a net profit attributable to the parent company of 16.9 million yuan, a year-on-year increase of 7.24%Zhitong·Aug 29, 2025 at 04:54 AM600518-2.16%
KMYY: Plans to sign a settlement agreement with related party Guangzhou Pharmaceutical Group to resolve historical debt issues for 43.5 million yuanZhitong·Jul 17, 2025 at 02:37 AM600518-2.16%
KMYY released its 2024 annual performance, with a net profit attributable to shareholders of RMB 8.5737 million, a year-on-year decrease of 91.64%Zhitong·Apr 18, 2025 at 07:50 AM600518-2.16%
